Lonestar Resources US Inc. (LONE) Analysts See $-0.17 EPS; Integra LifeSciences Holdings (IART) Had 8 Bullish Analysts

April 17, 2018 - By Peter Erickson

Analysts expect Lonestar Resources US Inc. (NASDAQ:LONE) to report $-0.17 EPS on May, 21.They anticipate $0.01 EPS change or 5.56% from last quarter’s $-0.18 EPS. After having $-0.03 EPS previously, Lonestar Resources US Inc.’s analysts see 466.67% EPS growth. The stock decreased 1.26% or $0.06 during the last trading session, reaching $4.69. About 103,227 shares traded or 1.61% up from the average. Lonestar Resources US Inc. (NASDAQ:LONE) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Among 16 analysts covering Integra Lifesciences Holdings Corp. (NASDAQ:IART), 8 have Buy rating, 0 Sell and 8 Hold. Therefore 50% are positive. Integra Lifesciences Holdings Corp. had 39 analyst reports since July 29, 2015 according to SRatingsIntel. Jefferies maintained it with “Buy” rating and $58.0 target in Friday, September 8 report. Oppenheimer maintained it with “Buy” rating and $5800 target in Thursday, March 29 report. The company was maintained on Wednesday, July 26 by Oppenheimer. As per Monday, October 30, the company rating was downgraded by Wells Fargo. The rating was maintained by Lake Street on Thursday, April 28 with “Hold”. Piper Jaffray maintained it with “Buy” rating and $56.0 target in Monday, September 11 report. Lake Street upgraded Integra LifeSciences Holdings Corporation (NASDAQ:IART) rating on Friday, October 28. Lake Street has “Buy” rating and $92 target. Raymond James upgraded the shares of IART in report on Wednesday, July 29 to “Outperform” rating. On Wednesday, August 26 the stock rating was maintained by Lake Street with “Hold”. As per Friday, October 27, the company rating was downgraded by JP Morgan. See Integra LifeSciences Holdings Corporation (NASDAQ:IART) latest ratings:

11/04/2018 Broker: JP Morgan Old Rating: Neutral New Rating: Neutral Old Target: $50 New Target: $55 Maintain
05/04/2018 Broker: BTIG Research Rating: Neutral New Target: $56 Initiates Coverage On
29/03/2018 Broker: Oppenheimer Rating: Buy New Target: $58.0000 Maintain
28/02/2018 Broker: JMP Securities Old Rating: Market Outperform New Rating: Market Outperform Old Target: $57 New Target: $60 Maintain
08/01/2018 Broker: Barclays Capital Rating: Hold New Target: $53.0
02/01/2018 Broker: Raymond James Old Rating: Outperform New Rating: Market Perform Old Target: $55 Downgrade
02/01/2018 Broker: Bank of America Old Rating: Buy New Rating: Neutral Downgrade
09/11/2017 Broker: RBC Capital Markets Rating: Hold New Target: $50.0 Maintain
30/10/2017 Broker: Wells Fargo Old Rating: Outperform New Rating: Market Perform Downgrade
27/10/2017 Broker: J.P. Morgan Rating: Hold New Target: $44.0 Downgrade

Investors sentiment decreased to 0.98 in Q4 2017. Its down 0.31, from 1.29 in 2017Q3. It turned negative, as 20 investors sold Integra LifeSciences Holdings Corporation shares while 70 reduced holdings. 23 funds opened positions while 65 raised stakes. 70.22 million shares or 2.95% more from 68.21 million shares in 2017Q3 were reported. Pub Sector Pension Investment Board reported 39,876 shares or 0.01% of all its holdings. Zurcher Kantonalbank (Zurich Cantonalbank), a Switzerland-based fund reported 3,806 shares. Credit Suisse Ag has 0% invested in Integra LifeSciences Holdings Corporation (NASDAQ:IART) for 87,254 shares. California Pub Employees Retirement Sys stated it has 128,561 shares. Cibc Asset Mgmt reported 0% stake. Riverhead Management Ltd Liability owns 3,426 shares. Gotham Asset Mgmt Ltd Liability Company holds 72,147 shares. Rafferty Asset Mgmt Lc has 0.01% invested in Integra LifeSciences Holdings Corporation (NASDAQ:IART). Illinois-based Envestnet Asset Mgmt has invested 0% in Integra LifeSciences Holdings Corporation (NASDAQ:IART). 4,787 are held by Peak6 Investments Lp. Falcon Point Cap Ltd Co holds 2.09% or 258,663 shares. Burney Communications holds 5,850 shares or 0.02% of its portfolio. Cambridge Trust owns 0.06% invested in Integra LifeSciences Holdings Corporation (NASDAQ:IART) for 19,669 shares. Goldman Sachs Grp Inc holds 0.01% of its portfolio in Integra LifeSciences Holdings Corporation (NASDAQ:IART) for 1.06 million shares. Conestoga Advsr Limited Company reported 0.01% in Integra LifeSciences Holdings Corporation (NASDAQ:IART).

The stock increased 0.47% or $0.26 during the last trading session, reaching $56.15. About 394,043 shares traded. Integra LifeSciences Holdings Corporation (NASDAQ:IART) has risen 29.35% since April 17, 2017 and is uptrending. It has outperformed by 17.80% the S&P500.

Integra LifeSciences Holdings Corporation develops, makes, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company has market cap of $4.43 billion. The firm operates through two divisions, Specialty Surgical Solutions; and Orthopedics and Tissue Technologies. It has a 68.48 P/E ratio. It offers neurosurgery and critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment.

Lonestar Resources US Inc., an independent gas and oil company, engages in the acquisition, development, and production of unconventional oil, natural gas liquids, and natural gas properties in the United States. The company has market cap of $115.55 million. The firm primarily focuses on Eagle Ford Shale properties in Texas counties. It currently has negative earnings. It also owns 28,655 net undeveloped acres in the Poplar West area of the Bakken Three Forks formation located in Roosevelt County, Montana.

Among 3 analysts covering Lonestar Resou… (NASDAQ:LONE), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Lonestar Resou… had 3 analyst reports since August 10, 2016 according to SRatingsIntel. The rating was initiated by Cowen & Co on Wednesday, August 10 with “Outperform”.

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Peter Erickson

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: